Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1967 2
1968 1
1997 2
1998 1
1999 2
2000 4
2001 4
2002 4
2003 4
2004 1
2005 1
2006 2
2007 3
2008 6
2009 11
2010 9
2011 9
2012 6
2013 8
2014 8
2015 6
2016 10
2017 11
2018 9
2019 12
2020 15
2021 15
2022 6
2023 5
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease.
Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario M, Feagan BG, Bojic D, Trang-Poisson C, Shen B, Altwegg R, Sands BE, Colombel JF, Carbonnel F; GETAID OBSERV-IBD, VICTORY Cohorts Collaboration*. Dulai PS, et al. Aliment Pharmacol Ther. 2020 Mar;51(5):553-564. doi: 10.1111/apt.15609. Epub 2019 Dec 22. Aliment Pharmacol Ther. 2020. PMID: 31867766 Free PMC article.
[Living with… Crohn's disease].
Nahon S. Nahon S. Rev Prat. 2023 Apr;73(4):419-420. Rev Prat. 2023. PMID: 37289161 French. No abstract available.
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier JC, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas JL, Carbonnel F, Bommelaer G, Coffin B, Roblin X, Van Assche G, Esteve M, Färkkilä M, Gisbert JP, Marteau P, Nahon S, de Vos M, Franchimont D, Mary JY, Colombel JF, Lémann M; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Laharie D, et al. Among authors: nahon s. Lancet. 2012 Dec 1;380(9857):1909-15. doi: 10.1016/S0140-6736(12)61084-8. Epub 2012 Oct 10. Lancet. 2012. PMID: 23063316 Clinical Trial.
[Crohn's disease and blood vessels].
Nahon S, Marteau P, Matuchansky C. Nahon S, et al. Gastroenterol Clin Biol. 1998 Feb;22(2):175-87. Gastroenterol Clin Biol. 1998. PMID: 9762192 Free article. Review. French. No abstract available.
A review investigating delays in Crohn's disease diagnosis.
Souaid C, Fares E, Primard P, Macaigne G, El Hajj W, Nahon S. Souaid C, et al. Among authors: nahon s. Clin Res Hepatol Gastroenterol. 2024 Nov 15;49(1):102500. doi: 10.1016/j.clinre.2024.102500. Online ahead of print. Clin Res Hepatol Gastroenterol. 2024. PMID: 39551466 Review.
[Investigation of iron deficiency].
Nahon S, Bouhnik Y. Nahon S, et al. Gastroenterol Clin Biol. 2000 May;24(5 Pt 2):B62-7. Gastroenterol Clin Biol. 2000. PMID: 10891766 Free article. Review. French. No abstract available.
Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID.
Amiot A, Seksik P, Reimund JM, Nachury M, Altwegg R, Bourreille A, Viennot S, Fumery M, Roblin X, Serrero M, Allez M, Painchart C, Chanteloup E, Vuitton L, Fotsing G, Buisson A, Coulibaly B, Nancey S, Gilletta C, Plastaras L, Abitbol V, Guillo L, Simon M, Nahon S, Laharie D, Peyrin-Biroulet L, Bouguen G; anti-TNF contraindication study group. Amiot A, et al. Among authors: nahon s. Dig Liver Dis. 2022 Oct;54(10):1350-1357. doi: 10.1016/j.dld.2022.04.011. Epub 2022 May 14. Dig Liver Dis. 2022. PMID: 35577685 Free article.
Efficacy of ferric carboxymaltose on haemoglobin response among older patients with gastrointestinal bleeding: a randomised clinical trial.
Richard N, Arab-Hocine N, Vannier M, Leblanc-Boubchir R, Pelaquier A, Boruchowicz A, Musikas M, Amil M, Fumery M, Nahon S, Arotcarena R, Gelsi E, Maurin A, Hébuterne X, Savoye G. Richard N, et al. Among authors: nahon s. Age Ageing. 2024 May 1;53(5):afae085. doi: 10.1093/ageing/afae085. Age Ageing. 2024. PMID: 38706390 Clinical Trial.
160 results